Charles River Laboratories International CRL
NYSE CRL
$303.50 +4.48 (+1.50%)
As of: Oct 14, 2026 · 2:10 PM EDT

Charles River Laboratories International (CRL) Asset Writedowns and Impairment (2022 - 2026)

Updated

Charles River Laboratories International's Asset Writedowns and Impairment was $10.42 million in Q2 2026, down 49.5% from $20.63 million a year earlier and down 34.3% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Charles River Laboratories International's Asset Writedowns and Impairment was $254.16 million through Jun 27, 2026, up 314.7% year-over-year; for FY2025, it was $259.08 million, up 20.5% from FY2024.

  • Asset Writedowns and Impairment has now increased for four consecutive years, with a four-year compound annual growth rate of 333.6% (FY2021 to FY2025).
  • In earlier years, Asset Writedowns and Impairment was $215 million in FY2024 (+413.0%), $41.91 million in FY2023 (+601.7%), $5.97 million in FY2022 (+714.9%) and $733,000 in FY2021.
  • Quarterly Asset Writedowns and Impairment has moved between -$7,000 (Q2 2023) and $222.9 million (Q4 2025) over five years.
  • Compared with a year earlier, Asset Writedowns and Impairment was higher in six of the last eight quarters, with growth averaging 125.9%.
  • The best year-over-year quarter for Asset Writedowns and Impairment over five years was Q4 2025 (growth of 725.5%); the worst was Q3 2024 (a decline of 80.4%).
  • Per Business Quant data, CRL's Asset Writedowns and Impairment in the three quarters before Q2 2026 was $15.86 million (Q1 2026), $222.9 million (Q4 2025) and $4.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.59 Bn 35.30 Bn 1.44 Bn
2 Medpace Holdings 17.35 Bn 15.41 Bn 201.64 Mn
3 Charles River Laboratories International 14.57 Bn 13.77 Bn 363.37 Mn
4 Icon 13.15 Bn 10.26 Bn 479.29 Mn
5 Fortrea Holdings 2.02 Bn 1.40 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 720.92 Mn -41.17 Mn 18.44 Mn
7 Evotec SE 502.55 Mn -1.11 Bn -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn
9 MindWalk Holdings 63.08 Mn 26.73 Mn 1.61 Mn
10 Natural Alternatives International 6.81 Mn -21.27 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 10.42 Mn
Mar 28, 2026 15.86 Mn
Dec 27, 2025 222.90 Mn
Sep 27, 2025 4.98 Mn
Jun 28, 2025 20.63 Mn
Mar 29, 2025 10.58 Mn
Dec 28, 2024 27.00 Mn
Sep 28, 2024 3.09 Mn
Jun 29, 2024 8.82 Mn
Mar 30, 2024 5.43 Mn
Dec 30, 2023 15.71 Mn
Sep 30, 2023 15.75 Mn
Jul 1, 2023 -7,000.00
Apr 1, 2023 10.46 Mn
Dec 31, 2022 5.97 Mn
API Access

Charles River Laboratories International Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=CRL&period=max&api_key=YOUR_API_KEY